iPierian
Acquired
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2008
- Business Model
- B2B
- Website
- bms.com
- Last Round
- Series CSep 2013
About
iPierian (formerly iZumi Bio) was a South San Francisco biopharmaceutical company founded in 2008 that pioneered the use of induced pluripotent stem cell (iPSC) technology to model and develop therapies for neurodegenerative diseases, including ALS and tauopathies. The company was acquired by Bristol-Myers Squibb in 2014 for up to $725 million.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account